According to GuruFocus’ list of 52-week lows, these guru stocks have reached their 52-week lows.
UnitedHealth Group reached the 52-week low of $223.22
The price of UnitedHealth Group Inc. (UNH, Financial) shares has declined to close to the 52-week low of $223.22, which is 23.3% off the 52-week high of $287.94. The company has a market cap of $214.19 billion.
Its shares traded with a price-earnings ratio of 18.31 and a price-sales ratio of 0.98 as of April 12. The trailing 12-month dividend yield is 1.61%. The forward dividend yield is 1.61%. The company had an annual average earnings growth of 13.70% over the past 10 years. GuruFocus rated UnitedHealth Group’s business predictability 5 out of 5 stars.
UnitedHealth is a diversified health care company in the United States. It designs products, provides services and applies technologies that improve access to health and well-being services, and make health care more affordable.
Earnings for the fourth quarter of 2018 were $1.8 billion.
Director Richard T. Burke sold 5,000 shares on March 19 for an average price of $257.32 per share. The share price has decreased 13.25% since then.
Bristol-Myers Squibb reached the 52-week low of $45.57
The price of Bristol-Myers Squibb Co. (BMY, Financial) shares has declined to close to the 52-week low of $45.57, which is 30.4% off the 52-week high of $63.69. The company has a market cap of $74.4 billion.
Shares traded with a price-earnings ratio of 15.14 and a price-sales ratio of 3.31 as of April 12. The trailing 12-month dividend yield is 3.55%. The forward dividend yield is 3.60%. The company had an annual average earnings growth of 18.40% over the past five years.
Bristol-Myers Squibb is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products.
Total revenue for the fourth quarter of 2018 was $5.97 billion, compared to $5.45 billion in the prior-year period.
CVS Health reached the 52-week low of $52.81
The price of CVS Health Corp. (CVS, Financial) shares has declined to close to the 52-week low of $52.81, which is 37% off the 52-week high of $82.15. The company has a market cap of $68.52 billion.
Its shares traded with a price-sales ratio of 0.28 as of April 12. The trailing 12-month dividend yield is 3.79%. The forward dividend yield is 3.79%. The company had an annual average earnings growth of 7.40% over the past 10 years.
CVS Health operates in the health care sector. Its primary business is that of operating retail pharmacies. The company has three reportable segments, namely Pharmacy Services, Retail/LTC and Corporate.
The net loss for the fourth quarter of 2018 was $421 million compared to net income of $3.29 billion in the prior-year quarter.
Cigna reached the 52-week low of $160.60
The price of Cigna Corp. (CI, Financial) shares has declined to close to the 52-week low of $160.60, which is 30.3% off the 52-week high of $226.61. The company has a market cap of $61.04 billion.
Its shares traded with a price-earnings ratio of 15.24 and a price-sales ratio of 0.89 as of April 12. The trailing 12-month dividend yield is 0.02%. The forward dividend yield is 0.02%.
Cigna operates in the health care industry, providing medical, dental, disability, life and accident insurance products.
Total revenue in the fourth quarter of 2018 was $14.30 billion, compared to $10.63 billion in the prior-year period.
Walgreens Boots Alliance reached the 52-week low of $53.45
The price of Walgreens Boots Alliance Inc. (WBA, Financial) shares has declined to close to the 52-week low of $53.45, which is 38.2% off the 52-week high of $86.31. The company has a market cap of $48.87 billion.
Its shares traded with a price-earnings ratio of 10.03 and a price-sales ratio of 0.38 as of April 12. The trailing 12-month dividend yield is 3.22%. The forward dividend yield is 3.29%. The company had an annual average earnings growth of 5.90% over the past 10 years. GuruFocus rated Walgreens Boots Alliance’s business predictability at 3.5 stars.
Walgreens is a pharmacy led health and wellbeing company. It operates retail pharmacy store chain in the United States. The firm sells and markets its products under brands such as Walgreens, Duane Reade, Boots and Alliance Healthcare.
Net earnings for the second quarter of 2019 was $1.2 billion compared with $1.3 billion for the same quarter a year ago.
Co-Chief Operating Officer Ornella Barra bought 18,000 shares on April 3 for an average price of $54.56 per share. The share price has fallen 2.03% since then.
Humana reached the 52-week low of $253.31
The price of Humana Inc. (HUM, Financial) shares has declined to close to the 52-week low of $253.31, which is 29.3% off the 52-week high of $355.88. The company has a market cap of $34.36 billion.
Its shares traded with a price-earnings ratio of 20.83 and a price-sales ratio of 0.62 as of April 12. The trailing 12-month dividend yield is 0.79%. The forward dividend yield is 0.79%. The company had an annual average earnings growth of 9.80% over the past 10 years. GuruFocus rated Humana’s business predictability 4.5 stars.
Humana is a health care company that offers insurance products and health and wellness services. Its segments include Retail, Employer Group and Healthcare Services.
Revenue for the fourth quarter of 2018 was $14.17 billion, up from $13.19 billion in the prior-year period.
Disclosure: I do not own stock in any of the companies mentioned in the article.
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
